Your browser doesn't support javascript.
Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
Smith, Debi L; Perkins, Rebecca B.
  • Smith DL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Perkins RB; Boston University School of Medicine/ Boston Medical Center, Boston, MA, USA. Electronic address: rbperkin@bu.edu.
Prev Med ; 159: 107070, 2022 06.
Article in English | MEDLINE | ID: covidwho-1799653
ABSTRACT
This invited commentary discusses the article by Richards et al. describing differences in rates of on-time HPV vaccination and cervical cancer screening in 2018 among enrollees in different insurance plans. The commentary focuses on the larger problem of low vaccination HPV rates and decreasing cervical cancer screening rates seen across all sectors. We outline challenges posed by the COVID-19 pandemic on HPV vaccination and cervical cancer screening, and discuss opportunities to improve cervical cancer prevention.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Female / Humans Language: English Journal: Prev Med Year: 2022 Document Type: Article Affiliation country: J.ypmed.2022.107070

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Female / Humans Language: English Journal: Prev Med Year: 2022 Document Type: Article Affiliation country: J.ypmed.2022.107070